[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Immunology with Professor Robert Clancy", "description": "Many thanks to Professor Clancy for a fascinating education on the science and clinical application of immunity.", "link": "https://www.youtube.com/watch?v=FPPnyzvO7J4", "date_published": "2022-01-23 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Omicron presentation in Israel", "description": "Check out Dr.Cohen's channel, Whats Up Doc, https://www.youtube.com/@whatsupdoc.\n\nMany thanks to Dr. Cohen for taking time out of a busy period.", "link": "https://www.youtube.com/watch?v=baEephIEB6g", "date_published": "2022-01-23 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Omicron, should I expose myself?", "description": "Link to free download of my 2 textbooks\n\nhttp://159.69.48.3/\n\nPhysiology book in hard copy\nhttps://www.ebay.co.uk/itm/154770452796?mkevt=1&mkcid=16&mkrid=710-127635-2958-0\n\nPathophysiology book in hard copy\nhttps://www.ebay.co.uk/itm/154770451780?mkevt=1&mkcid=16&mkrid=710-127635-2958-0\n\nUS variants data\n\nhttps://covid.cdc.gov/covid-data-tracker/#variant-proportions\n\nhttps://www.nytimes.com/interactive/2022/01/22/science/charting-omicron-infection.html\n\nUS omicron history\n\nNovember 29\n\nIndex patient, 48 year old unvaccinated man, Nigeria\n\nNebraska, 6 people diagnosed by PCR and genomic sequencing\n\nOnset was 73 hours (range = 33\u201375 hours)\n\nIncubation period\n\nhttps://www.cdc.gov/mmwr/volumes/70/wr/mm705152e3.htm\n\nOriginal version, five days\n\nThe Delta variant, four days\n\nOmicron, 2 to 3 days\n\nViral Load\n\nhttps://www.nejm.org/doi/full/10.1056/NEJMc2102507\n\nAlpha and Delta variants\n\nPeak viral load 3 days after infection\n\nClear the virus about six days after that\n\nInfectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron \n\nhttps://www.medrxiv.org/content/10.1101/2022.01.10.22269010v2.full.pdf\n\nOmicron and Delta produced similar levels of infectious virus\n\nInfections a day shorter with omicron compared to delta\n\nOmicron infects upper airways as opposed to lungs\n\nOmicron antibodies neutralise delta virus\n\nOffshoot of Omicron variant, England\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1046614/12-january-2022-risk-assessment-SARS-Omicron_VOC-21NOV-01_B.1.1.529.pdf\n\nhttps://www.theguardian.com/world/live/2022/jan/22/coronavirus-live-japan-and-taiwan-report-omicron-surges-ireland-lifts-restrictions\n\nBA.2 may be even more contagious than original omicron\n\nUK Health Security Agency\n\nDesignating BA.2 a variant under investigation\n\nincreasing numbers of BA.2 sequences identified both domestically and internationally\n\nMay have an increased growth rate over BA.1\n\nVaccine effectiveness with omicron\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1048395/technical-briefing-34-14-january-2022.pdf\n\nAfter a 2-dose primary course of vaccination\n\nVaccine protection against mild disease has largely disappeared by 20 weeks after vaccination\n\nAfter a booster dose\n\nProtection initially increases to around 65 to 70%\nbut drops to 45 to 50% from 10+ weeks\n\nTherefore\n\nIt is therefore likely that current vaccines offer limited long-term protection against infection or transmission. \n\nProtection against severe disease\n\nVaccine effectiveness against hospitalisation is estimated at 92%\n\nand remains high at 83% 10+ weeks after the booster dose\n\nJohn\u2019s booster\n\n20th November\n\nSo my protection against hospitalisation goes down from 92% to 83% by soon", "link": "https://www.youtube.com/watch?v=4RSahdFuemE", "date_published": "2022-01-22 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]